James C. Foster
CIK: 0001141722
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Oct 22, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Exercise(M)Direct24K shares at avg. $244.41$5.9M - Oct 22, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct24K shares at avg. $350.00$8.4M - Aug 25, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct33.6K shares at avg. $300.00$10.1M - Aug 25, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Exercise(M)Direct12.4K shares at avg. $208.44$2.6M - Aug 25, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Exercise(M)Direct21.1K shares at avg. $194.12$4.1M - Aug 10, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct28.7K shares at avg. $275.00$7.9M - Aug 10, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Exercise(M)Direct28.7K shares at avg. $179.66$5.2M - Jun 29, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct75K shares at avg. $225.00$16.9M - Jun 5, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Gift(G)Indirect10K shares- - Jun 5, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Gift(G)Indirect10K shares- - Jun 5, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Gift(G)Indirect20K shares- - Jun 5, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Gift(G)Indirect153.4K shares- - Jun 5, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Gift(G)Direct153.4K shares- - Jun 5, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Gift(G)Direct20K shares- - May 30, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct1.6K shares at avg. $180.71$288K - May 8, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct1.4K shares at avg. $177.62$255K - May 8, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct422 shares at avg. $177.62$75K - Mar 2, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct16.8K shares at avg. $178.61$3.0M - Jan 30, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct14.7K shares at avg. $211.68$3.1M - Jan 30, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct39K shares- - May 30, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct17.3K shares at avg. $135.63$2.3M - Feb 20, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Purchase(P)Direct6.1K shares at avg. $165.01$1.0M - Jan 31, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct6.8K shares at avg. $165.57$1.1M - Jan 31, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct19.6K shares- - Nov 8, 2024CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Gift(G)Direct4.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Exercise(M) | 24,042 | $244.41 | $5,876,105 | Direct |
| Oct 22, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 24,042 | $350.00 | $8,414,700 | Direct |
| Aug 25, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 33,561 | $300.00 | $10,068,300 | Direct |
| Aug 25, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Exercise(M) | 12,429 | $208.44 | $2,590,701 | Direct |
| Aug 25, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Exercise(M) | 21,132 | $194.12 | $4,102,144 | Direct |
| Aug 10, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 28,733 | $275.00 | $7,901,575 | Direct |
| Aug 10, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Exercise(M) | 28,733 | $179.66 | $5,162,171 | Direct |
| Jun 29, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 75,000 | $225.00 | $16,875,000 | Direct |
| Jun 5, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift(G) | 10,000 | - | $0 | Indirect |
| Jun 5, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift(G) | 10,000 | - | $0 | Indirect |
| Jun 5, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift(G) | 20,000 | - | $0 | Indirect |
| Jun 5, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift(G) | 153,361 | - | $0 | Indirect |
| Jun 5, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift(G) | 153,361 | - | $0 | Direct |
| Jun 5, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift(G) | 20,000 | - | $0 | Direct |
| May 30, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 1,596 | $180.71 | $288,413 | Direct |
| May 8, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 1,438 | $177.62 | $255,418 | Direct |
| May 8, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 422 | $177.62 | $74,956 | Direct |
| Mar 2, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 16,796 | $178.61 | $2,999,934 | Direct |
| Jan 30, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 14,664 | $211.68 | $3,104,076 | Direct |
| Jan 30, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 39,031 | - | $0 | Direct |
| May 30, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 17,253 | $135.63 | $2,340,024 | Direct |
| Feb 20, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Purchase(P) | 6,075 | $165.01 | $1,002,436 | Direct |
| Jan 31, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 6,827 | $165.57 | $1,130,346 | Direct |
| Jan 31, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 19,608 | - | - | Direct |
| Nov 8, 2024 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift(G) | 4,500 | - | $0 | Direct |
1-25 of 25 transactions
About FOSTER JAMES C
FOSTER JAMES C (SEC CIK 0001141722) files insider reports with the SEC as Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
Signal8 holds 13 ownership filings by FOSTER JAMES C, all Form 4s, filed between Nov 12, 2024 and Oct 26, 2026. Those filings report 25 transactions, from Nov 8, 2024 to Oct 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FOSTER JAMES C's filings is in WILMINGTON, MA.
Recent filings by FOSTER JAMES C
- Oct 22, 2026: Option exercise of CRL shares (Form 4, code M).
- Oct 22, 2026: Open-market sale of CRL shares (Form 4, code S).
- Aug 25, 2026: Open-market sale of CRL shares (Form 4, code S).
- Aug 25, 2026: Option exercises of CRL shares (2 lines, Form 4, code M).
- Aug 10, 2026: Open-market sale of CRL shares (Form 4, code S).
Other insiders filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Parisotto Shannon M, CEVP, Disc & Safety Assessment
- Coleman Glenn, EVP & Chief Financial Officer
- Girshick Birgit, Chief Executive Officer
- Andrews Nancy C, Director
- LaPlume Joseph W, EVP, Corp Strategy & Develop
- Knell Michael Gunnar, SVP, Finance and CAO